Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 10, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Allan D Sniderman1, George Thanassoulis, Patrick Couture
1Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Centre, Montreal, Quebec, Canada.
No abstract available in PubMed .